GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » Issuance of Debt

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Issuance of Debt : ¥250.0 Mil (TTM As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co Issuance of Debt?

Zhejiang Ausun Pharmaceutical Co's Issuance of Debt for the three months ended in Sep. 2023 was ¥0.0 Mil.

Zhejiang Ausun Pharmaceutical Co's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2023 was ¥250.0 Mil.

Zhejiang Ausun Pharmaceutical Co Issuance of Debt Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Ausun Pharmaceutical Co Issuance of Debt Chart

Zhejiang Ausun Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 158.95 116.90 81.00 219.80 235.05

Zhejiang Ausun Pharmaceutical Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 50.00 100.00 100.00 -

Zhejiang Ausun Pharmaceutical Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥250.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Ausun Pharmaceutical Co Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » Issuance of Debt
Comparable Companies
SHSE:688526 SHSE:688315 SZSE:300841 SHSE:600866 SHSE:688202 SZSE:002275 SHSE:600645 SZSE:300049 SHSE:688382 SHSE:688319 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Website
http://www.ausunpharm.com
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Headlines

No Headlines